Physiomics (PYC)

 

Latest News

Update: Two Further Extension Projects

RNS Number: 0270G Physiomics PLC 24 May 2017 Physiomics plc ("Physiomics") or ("the Company") Update: two further extension projects to advance oncology candidate with global pharma company Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has been contracted for two further extensions to a Virt...

Physiomics to Present at BioTrinity 2017

RNS Number: 2352E Physiomics PLC 05 May 2017 Physiomics Plc ("Physiomics" or "the Company") Physiomics to Present at BioTrinity 2017 Oxford, UK, 5 th May 2017: Physiomics is pleased to announce that it will attend BioTrinity 2017. BioTrinity is one of Europe's leading Biopartnering and Investment Conferences, to be held on 8-10 May at the Novotel London W...

Physiomics' losses rise

Physiomics has reported an operating loss of 263,509 for the six month period ended 31 December, compared to a restated lo...

Interim Results Statement

RNS Number: 4688A Physiomics PLC 24 March 2017 Physiomics Plc ("Physiomics" or "the Company") Interim Results Statement for the six month period ended 31 December 2016 Oxford, UK, 24 March 2017: The Board of Physiomics Plc (AIM: PYC), a UK-based systems biology company, today announces its financial results for the six months ended 31 December 2...

All News

DateHeadlineSource
24-05-17Update: Two Further Extension ProjectsRNS
05-05-17Physiomics to Present at BioTrinity 2017RNS
24-03-17Physiomics' losses riseStockMarketWire
24-03-17Interim Results StatementRNS
11-01-17Physiomics makes good progress on strategic objectivesStockMarketWire
11-01-17Company UpdateRNS
06-01-17Physiomics confirms award of Innovate UK grantStockMarketWire
06-01-17Confirmation of Award of Innovate UK GrantRNS
22-12-16Director Deals - Physiomics PLC (PYC)StockMarketWire
22-12-16Director DealingRNS
22-12-16Issue of OptionsRNS
16-12-16Physiomics resolutions passed at AGMStockMarketWire
16-12-16Result of AGMRNS
05-12-16Physiomics notes payment for in-silico modelling of inhibitorStockMarketWire
05-12-16Payment for in-silico modelling of inhibitorRNS
23-11-16Posting of Financial Results and Notice of AGMRNS
22-11-16Provisional Award of Innovate UK GrantRNS
27-10-16Physiomics turnover up 26%StockMarketWire
27-10-16Final Results for the year ended 30 June 2016RNS
26-10-16Presentation at Conference on PharmacometricsRNS
25-10-16Physiomics notes directorate changeStockMarketWire
25-10-16Directorate ChangeRNS
28-09-16Advisor ChangesRNS
21-09-16Physiomics updates on placing, acquisitionStockMarketWire
21-09-16Placing and Update on AcquisitionRNS
07-09-16Physiomics passes all AGM resolutionsStockMarketWire
07-09-16Result of GMRNS
22-08-16Notice of General MeetingRNS
18-08-16Physiomics inks SPA with BioMotiStockMarketWire
18-08-16Signing of Share Purchase Agreement with BioMotiRNS
16-08-16Physiomics appoints joint broker StockMarketWire
16-08-16Advisor ChangesRNS
16-05-16Physiomics extends Virtual Tumour Project StockMarketWire
16-05-16Extensions for Virtual Tumour ProjectRNS
03-05-16Appointment of part-time Head of FinanceRNS
18-04-16Physiomics appoints new CEOStockMarketWire
18-04-16Physiomics Appoints New Chief Executive OfficerRNS
06-04-16Physiomics to present at AACRStockMarketWire
06-04-16Virtual Tumour Developments Presentation at AACRRNS
04-04-16Physiomics extends contract with pharma companyStockMarketWire

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory